• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用细胞膜包裹细菌进行伪装。

Camouflaging bacteria by wrapping with cell membranes.

机构信息

Institute of Molecular Medicine, State Key Laboratory of Oncogenes and Related Genes, Shanghai Institute of Cancer, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 200011, Shanghai, China.

Department of Ophthalmology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, 200011, Shanghai, China.

出版信息

Nat Commun. 2019 Aug 6;10(1):3452. doi: 10.1038/s41467-019-11390-8.

DOI:10.1038/s41467-019-11390-8
PMID:31388002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6684626/
Abstract

Bacteria have been extensively utilized for bioimaging, diagnosis and therapy given their unique characteristics including genetic manipulation, rapid proliferation and disease site targeting specificity. However, clinical translation of bacteria for these applications has been largely restricted by their unavoidable side effects and low treatment efficacies. Engineered bacteria for biomedical applications ideally need to generate only a low inflammatory response, show slow elimination by macrophages, low accumulation in normal organs, and almost unchanged inherent bioactivities. Here we describe a set of stealth bacteria, cell membrane coated bacteria (CMCB), meeting these requirement. Our findings are supported by evaluation in multiple mice models and ultimately demonstrate the potential of CMCB to serve as efficient tumor imaging agents. Stealth bacteria wrapped up with cell membranes have the potential for a myriad of bacterial-mediated biomedical applications.

摘要

鉴于其独特的特性,包括遗传操作、快速增殖和疾病部位靶向特异性,细菌已被广泛用于生物成像、诊断和治疗。然而,细菌在这些应用中的临床转化在很大程度上受到其不可避免的副作用和低治疗效果的限制。用于生物医学应用的工程细菌理想情况下只需产生低炎症反应,被巨噬细胞缓慢清除,在正常器官中低积累,并几乎保持不变的固有生物活性。在这里,我们描述了一组满足这些要求的隐形细菌,细胞膜包被的细菌(CMCB)。我们的研究结果得到了多种小鼠模型评估的支持,并最终证明了 CMCB 作为有效肿瘤成像剂的潜力。用细胞膜包裹的隐形细菌有可能应用于各种细菌介导的生物医学应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/557e/6684626/572fadc529c4/41467_2019_11390_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/557e/6684626/36b9e435b4ae/41467_2019_11390_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/557e/6684626/7a29ee45a566/41467_2019_11390_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/557e/6684626/3563f03e64f5/41467_2019_11390_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/557e/6684626/21149858bdf5/41467_2019_11390_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/557e/6684626/d93f9cc3e56d/41467_2019_11390_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/557e/6684626/572fadc529c4/41467_2019_11390_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/557e/6684626/36b9e435b4ae/41467_2019_11390_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/557e/6684626/7a29ee45a566/41467_2019_11390_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/557e/6684626/3563f03e64f5/41467_2019_11390_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/557e/6684626/21149858bdf5/41467_2019_11390_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/557e/6684626/d93f9cc3e56d/41467_2019_11390_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/557e/6684626/572fadc529c4/41467_2019_11390_Fig6_HTML.jpg

相似文献

1
Camouflaging bacteria by wrapping with cell membranes.用细胞膜包裹细菌进行伪装。
Nat Commun. 2019 Aug 6;10(1):3452. doi: 10.1038/s41467-019-11390-8.
2
Synthetic microbes as drug delivery systems.作为药物递送系统的合成微生物。
ACS Synth Biol. 2015 Apr 17;4(4):358-64. doi: 10.1021/sb500258b. Epub 2014 Aug 13.
3
Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment.生物界面自组装生成脂质膜包裹的细菌,用于增强口服递送和治疗效果。
Nat Commun. 2019 Dec 19;10(1):5783. doi: 10.1038/s41467-019-13727-9.
4
Tweak to Treat: Reprograming Bacteria for Cancer Treatment.微调以治疗:为癌症治疗重新编程细菌。
Trends Cancer. 2021 May;7(5):447-464. doi: 10.1016/j.trecan.2020.11.004. Epub 2020 Dec 8.
5
Engineering Macrophages for Cancer Immunotherapy and Drug Delivery.用于癌症免疫治疗和药物递送的工程化巨噬细胞
Adv Mater. 2020 Oct;32(40):e2002054. doi: 10.1002/adma.202002054. Epub 2020 Aug 28.
6
Engineering Circulating Tumor Cells as Novel Cancer Theranostics.工程化循环肿瘤细胞作为新型癌症治疗与诊断一体化策略。
Theranostics. 2020 Jun 29;10(17):7925-7937. doi: 10.7150/thno.44259. eCollection 2020.
7
Surface-modified bacteria: synthesis, functionalization and biomedical applications.表面修饰细菌:合成、功能化及生物医学应用。
Chem Soc Rev. 2023 Oct 2;52(19):6617-6643. doi: 10.1039/d3cs00369h.
8
Cellular Bioparticulates with Therapeutics for Cancer Immunotherapy.用于癌症免疫治疗的细胞生物颗粒
Bioconjug Chem. 2018 Mar 21;29(3):702-708. doi: 10.1021/acs.bioconjchem.7b00619. Epub 2017 Dec 11.
9
Image-guided drug delivery: preclinical applications and clinical translation.图像引导下的药物递送:临床前应用与临床转化
Expert Opin Drug Deliv. 2015 Aug;12(8):1203-7. doi: 10.1517/17425247.2015.1059420. Epub 2015 Jun 17.
10
Cell membrane-engineered hybrid soft nanocomposites for biomedical applications.用于生物医学应用的细胞膜工程化混合软纳米复合材料。
J Mater Chem B. 2020 Jul 8;8(26):5578-5596. doi: 10.1039/d0tb00472c.

引用本文的文献

1
A multifunctional living hydrogel for the synergistic management of infected diabetic wounds.一种用于协同管理感染性糖尿病伤口的多功能活性水凝胶。
Mater Today Bio. 2025 Apr 22;32:101787. doi: 10.1016/j.mtbio.2025.101787. eCollection 2025 Jun.
2
Modulation of oral vaccine efficacy by the gut microbiota.肠道微生物群对口服疫苗效力的调节作用。
NPJ Vaccines. 2025 Aug 1;10(1):179. doi: 10.1038/s41541-025-01240-8.
3
Self-Adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery.用于靶向肿瘤定植和局部治疗递送的自调节工程益生菌

本文引用的文献

1
Bacteroides thetaiotaomicron.拟杆菌属厚壁菌门。
Trends Microbiol. 2018 Nov;26(11):966-967. doi: 10.1016/j.tim.2018.08.005. Epub 2018 Sep 4.
2
Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis.中性粒细胞膜包覆的纳米颗粒抑制滑膜炎症并减轻炎症性关节炎中的关节损伤。
Nat Nanotechnol. 2018 Dec;13(12):1182-1190. doi: 10.1038/s41565-018-0254-4. Epub 2018 Sep 3.
3
Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy.细菌驱动的乏氧靶向用于联合生物治疗和光热治疗。
Adv Sci (Weinh). 2025 Aug;12(31):e06486. doi: 10.1002/advs.202406486. Epub 2025 May 28.
4
Engineered Spirulina platensis for treating rheumatoid arthritis and restoring bone homeostasis.工程化钝顶螺旋藻用于治疗类风湿性关节炎和恢复骨稳态。
Nat Commun. 2025 May 13;16(1):4434. doi: 10.1038/s41467-025-59579-4.
5
Recent Advances in Spatiotemporal Manipulation of Engineered Bacteria for Precision Cancer Therapy.用于精准癌症治疗的工程菌时空操纵的最新进展
Int J Nanomedicine. 2025 May 7;20:5859-5872. doi: 10.2147/IJN.S516523. eCollection 2025.
6
Biocompatible cloaking of bacteria for effective tumor imaging and therapy.用于有效肿瘤成像和治疗的细菌生物相容性隐形技术。
Mater Today Bio. 2025 Apr 22;32:101788. doi: 10.1016/j.mtbio.2025.101788. eCollection 2025 Jun.
7
Microfluidic-derived montmorillonite composite microparticles for oral codelivery of probiotic biofilm and postbiotics.用于益生菌生物膜和后生元口服共递送的微流控衍生蒙脱石复合微粒
Sci Adv. 2025 Mar 21;11(12):eadt2131. doi: 10.1126/sciadv.adt2131. Epub 2025 Mar 19.
8
Living Bacteria: A New Vehicle for Vaccine Delivery in Cancer Immunotherapy.活细菌:癌症免疫治疗中疫苗递送的新载体。
Int J Mol Sci. 2025 Feb 26;26(5):2056. doi: 10.3390/ijms26052056.
9
Precision tumor treatment utilizing bacteria: principles and future perspectives.利用细菌的精准肿瘤治疗:原理与未来展望。
Appl Microbiol Biotechnol. 2025 Jan 4;109(1):2. doi: 10.1007/s00253-024-13378-x.
10
Non-pathogenic Trojan horse triggers mitophagy through PINK1/Parkin pathway to discourage colon cancer.非致病性特洛伊木马通过PINK1/Parkin途径触发线粒体自噬以抑制结肠癌。
Mater Today Bio. 2024 Sep 27;29:101273. doi: 10.1016/j.mtbio.2024.101273. eCollection 2024 Dec.
ACS Nano. 2018 Jun 26;12(6):5995-6005. doi: 10.1021/acsnano.8b02235. Epub 2018 May 29.
4
Optically-controlled bacterial metabolite for cancer therapy.光控细菌代谢物用于癌症治疗。
Nat Commun. 2018 Apr 26;9(1):1680. doi: 10.1038/s41467-018-03233-9.
5
Attenuated Salmonella VNP20009 mutant (ΔhtrA) is a promising candidate for bacteria-mediated tumour therapy in hosts with TNFR1 deficiency.减毒沙门氏菌VNP20009突变体(ΔhtrA)是TNFR1缺陷宿主中细菌介导肿瘤治疗的一个有前景的候选者。
Lett Appl Microbiol. 2018 Jul;67(1):97-103. doi: 10.1111/lam.12999. Epub 2018 May 24.
6
Bacteria-Mediated Tumor Therapy Utilizing Photothermally-Controlled TNF-α Expression via Oral Administration.经口服给予光热控制的 TNF-α 表达实现细菌介导的肿瘤治疗。
Nano Lett. 2018 Apr 11;18(4):2373-2380. doi: 10.1021/acs.nanolett.7b05323. Epub 2018 Mar 22.
7
Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy.巨噬细胞膜包覆纳米颗粒用于肿瘤靶向化疗。
Nano Lett. 2018 Mar 14;18(3):1908-1915. doi: 10.1021/acs.nanolett.7b05263. Epub 2018 Feb 23.
8
Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts.用于哺乳动物宿主中微生物的非侵入性成像的声学报告基因。
Nature. 2018 Jan 3;553(7686):86-90. doi: 10.1038/nature25021.
9
Supramolecularly engineered phospholipids constructed by nucleobase molecular recognition: upgraded generation of phospholipids for drug delivery.通过碱基分子识别构建的超分子工程磷脂:用于药物递送的新一代升级磷脂。
Chem Sci. 2015 Jul 1;6(7):3775-3787. doi: 10.1039/c5sc01188d. Epub 2015 May 12.
10
A phase I clinical study to evaluate safety of orally administered, genetically engineered serovar for canine osteosarcoma.一项评估口服基因工程血清型用于犬骨肉瘤安全性的I期临床研究。
Vet Med Sci. 2016 Jun 6;2(3):179-190. doi: 10.1002/vms3.32. eCollection 2016 Aug.